Free Trial

Microbix Biosystems (MBX) Competitors

Microbix Biosystems logo
C$0.26 0.00 (0.00%)
As of 12:34 PM Eastern

MBX vs. SCYB, COM, NVH, IGX, MDNA, PDP, SVA, COV, EMH, and PMN

Should you be buying Microbix Biosystems stock or one of its competitors? The main competitors of Microbix Biosystems include Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Medicenna Therapeutics (MDNA), Pediapharm (PDP), Sernova (SVA), Covalon Technologies (COV), Emerald Health Therapeutics (EMH), and ProMIS Neurosciences (PMN). These companies are all part of the "biotechnology" industry.

Microbix Biosystems vs. Its Competitors

Microbix Biosystems (TSE:MBX) and Scythian Biosciences (CVE:SCYB) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

Microbix Biosystems has a net margin of 13.86% compared to Scythian Biosciences' net margin of 0.00%. Microbix Biosystems' return on equity of 12.65% beat Scythian Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems13.86% 12.65% 3.82%
Scythian Biosciences N/A N/A N/A

In the previous week, Microbix Biosystems' average media sentiment score of 0.00 equaled Scythian Biosciences'average media sentiment score.

Company Overall Sentiment
Microbix Biosystems Neutral
Scythian Biosciences Neutral

0.2% of Microbix Biosystems shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Microbix Biosystems has higher revenue and earnings than Scythian Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$21.13M1.69C$3.39M-C$0.00-127.50
Scythian BiosciencesN/AN/AN/AN/AN/A

Summary

Microbix Biosystems beats Scythian Biosciences on 6 of the 6 factors compared between the two stocks.

Get Microbix Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBX vs. The Competition

MetricMicrobix BiosystemsBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$35.77MC$231.22MC$6.11BC$9.74B
Dividend Yield2.30%3.80%5.66%6.47%
P/E Ratio-127.5094.7085.7026.97
Price / Sales1.696,040.95528.3610.87
Price / Cash4.1313.1926.3083.29
Price / Book1.23113.4812.875.77
Net IncomeC$3.39M-C$90.99MC$3.30BC$301.20M
7 Day Performance-1.92%4.75%4.10%2.25%
1 Month Performance8.51%7.68%7.37%7.77%
1 Year Performance-27.14%642.97%75.42%42.90%

Microbix Biosystems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBX
Microbix Biosystems
N/AC$0.26
flat
N/A-27.1%C$35.77MC$21.13M-127.50N/A
SCYB
Scythian Biosciences
N/AC$3.49
-5.9%
N/A+0.0%C$102.38MN/A0.00N/AHigh Trading Volume
COM
138267 (COM.TO)
N/AN/AN/AN/AC$102.19MN/A0.00N/A
NVH
Novoheart
N/AC$0.53
+1.9%
N/A+0.0%C$99.98MC$423.50K-13.95N/A
IGX
IntelGenx Technologies
N/AC$0.58
+1.8%
N/A+0.0%C$87.32MC$1.75M-7.442,050Gap Up
MDNA
Medicenna Therapeutics
N/AC$0.98
+2.1%
N/A-55.0%C$81.74MN/A-6.1320
PDP
Pediapharm
N/AC$0.30
+1.7%
N/A+0.0%C$66.36MC$11.16M-4.11N/A
SVA
Sernova
N/AC$0.18
+5.9%
N/A-26.9%C$59.16MN/A-3.601,959Gap Down
COV
Covalon Technologies
N/AC$2.08
flat
N/A-34.5%C$57.03MC$32.99M23.11N/A
EMH
Emerald Health Therapeutics
N/AC$0.26
-3.8%
N/A+0.0%C$52.28MC$13.02M-0.37161
PMN
ProMIS Neurosciences
N/AN/AN/AN/AC$51.48MC$7.56K-1.786Gap Up
High Trading Volume

Related Companies and Tools


This page (TSE:MBX) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners